Cargando…

Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019

Coronavirus disease 2019 (COVID-19) has become a global pandemic. It is still uncontrolled in most countries and no therapies are currently available. Various drugs are under investigation for its treatment. The disease is known to have worse outcomes in patients who have underlying cardiovascular d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aggarwal, Gaurav, Henry, Brandon Michael, Aggarwal, Saurabh, Bangalore, Sripal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228893/ https://www.ncbi.nlm.nih.gov/pubmed/32425199 http://dx.doi.org/10.1016/j.amjcard.2020.04.054

Ejemplares similares

Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
por: Aggarwal, Gaurav, et al.
Publicado: (2020)

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis
por: Henry, Brandon Michael, et al.
Publicado: (2020)

Disparities in case frequency and mortality of coronavirus disease 2019 (COVID-19) among various states in the United States
por: Loomba, Rohit S., et al.
Publicado: (2020)

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
por: Devabhaktuni, Madhuri, et al.
Publicado: (2009)

Cardiovascular Risk Factors: It's Time to Focus on Variability!
por: Barnett, Mallory P., et al.
Publicado: (2020)

Plausible mechanisms explaining the role of cucurbitacins as potential therapeutic drugs against coronavirus 2019
por: Kapoor, Neha, et al.
Publicado: (2020)

Natural and Synthetic Drugs as Potential Treatment for Coronavirus Disease 2019 (COVID-2019)
por: Farooq, Saba, et al.
Publicado: (2020)

Efficacy and safety of potential vaccine candidates against coronavirus disease 2019: A systematic review
por: Kumar, Subodh, et al.
Publicado: (2021)

Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines
por: Tuli, Hardeep Singh, et al.
Publicado: (2021)

Potential adverse effects of coronavirus disease 2019 on the cardiovascular system
por: Bing-Yin, Wang, et al.
Publicado: (2021)

Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Coronavirus disease 2019 and cardiovascular disease
por: Song, Jenn-Yeu, et al.
Publicado: (2023)

Coronavirus Disease 2019: Coronaviruses and Blood Safety
por: Chang, Le, et al.
Publicado: (2020)

Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Thromboelastography determined dynamics of blood coagulation and its correlation with complications and outcomes in patients with coronavirus disease 2019
por: Sehgal, Tushar, et al.
Publicado: (2022)

The State of Coronary Thrombus Aspiration
por: Pruthi, Sonal, et al.
Publicado: (2022)

Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment
por: Ye, Qing, et al.
Publicado: (2020)

Coronavirus Disease 2019–Associated Coagulopathy
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Henry, Brandon Michael, et al.
Publicado: (2020)

Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
por: Ong, Sean Wei Xiang, et al.
Publicado: (2020)

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
por: Makani, Harikrishna, et al.
Publicado: (2013)

Dexamethasone: a corticosteroid drug for the treatment of coronavirus disease 2019
por: Riaz, Muhammad, et al.
Publicado: (2022)

Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines—Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials
por: Buchman, Timothy G., et al.
Publicado: (2021)

Cardiovascular and Venous Thromboembolic Risk With Janus Kinase Inhibitors in Immune‐Mediated Inflammatory Diseases: A Systematic Review and Meta‐Analysis of Randomized Trials
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2022)

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
por: Fan, Hua-Hao, et al.
Publicado: (2020)

Diagnosis and treatment strategy of coronavirus disease 2019 with cardiovascular disease in elderly patients
por: Cheng, Biao
Publicado: (2020)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Komiyama, Maki, et al.
Publicado: (2021)

Effectiveness and safety of coronavirus disease 2019 vaccines
por: Shi, Ting, et al.
Publicado: (2023)

Cardiovascular Disease, Intensive Care, and Mortality in Coronavirus Disease 2019 Patients: A Meta-Analysis
por: Sarfraz, Zouina, et al.
Publicado: (2022)

Drug treatment of coronavirus disease 2019 (COVID-19) in China.
por: Jin, Zhe, et al.
Publicado: (2020)

Revascularization and survival in multivessel coronary artery disease in ischemia
por: Maron, David J., et al.
Publicado: (2022)

Updates on laboratory investigations in coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Coronavirus disease 2019 and cardiovascular system: A narrative review
por: Kwenandar, Felix, et al.
Publicado: (2020)

Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019
por: Hendren, Nicholas S., et al.
Publicado: (2020)

Cardiovascular comorbidities and complications associated with coronavirus disease 2019
por: Mahajan, Kunal, et al.
Publicado: (2020)

Coronavirus disease 2019 and the cardiovascular system: Impacts and implications
por: Gupta, Mohit D., et al.
Publicado: (2020)

Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications
por: Ma, Lulu, et al.
Publicado: (2021)

Cardiovascular Involvement in Patients with 2019 Novel Coronavirus Disease
por: Li, Chenze, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c8l1do2u9i55p8lejm7jjfsth4